Skin tumors in xeroderma pigmentosum: Evaluation of a large series and a literature review

2021 ◽  
Author(s):  
Can Baykal ◽  
Tuğba Atcı ◽  
Zeynep Yılmaz ◽  
Nesimi Büyükbabani
Keyword(s):  
Literature Review ◽  
Xeroderma Pigmentosum ◽  
Skin Tumors ◽  
Large Series

Segregation and expression analyses of hyaluronan-binding protein 2 (HABP2): insights from a large series of familial non-medullary thyroid cancers and literature review

2017 ◽  
Vol 86 (6) ◽  
pp. 837-844 ◽  
Author(s):  
Carla Colombo ◽  
Marina Muzza ◽  
Maria Carla Proverbio ◽  
Giulia Ercoli ◽  
Michela Perrino ◽  
...  
Keyword(s):  
Literature Review ◽  
Binding Protein ◽  
Large Series ◽  
Thyroid Cancers ◽  
Medullary Thyroid ◽  
Hyaluronan Binding

scholarly journals Xeroderma Pigmentosum in Children: Report of 4 Cases

Health Scope ◽  
2020 ◽  
Vol 9 (4) ◽  
Author(s):  
Ghasem Miri-Aliabad ◽  
Leila Asgarzadeh
Keyword(s):  
Xeroderma Pigmentosum ◽  
Genetic Disorder ◽  
Skin Aging ◽  
Incidence Rates ◽  
Skin Tumors ◽  
The Body ◽  
Malignant Skin Tumors ◽  
Malignant Skin ◽  
Defective Dna Repair ◽  
Autosomal Recessive Pattern

: Xeroderma pigmentosum (XP) is a rare genetic disorder inherited in an autosomal recessive pattern. Patients with XP are extremely sensitive to ultraviolet (UV) radiation that leads to defective DNA repair. People with XP often suffer from problems in the eyes, face, neck, and other areas of the body, frequently exposed to sunlight. It is characterized by photosensitivity, dry skin, pigmentary changes of the skin, premature skin aging, and a considerable increase in incidence rates of malignant skin tumors. There is no cure for XP. In this article, we have described four patients from two families, three of whom had malignant skin tumors.

ONCOGENE ACTIVATION IN ULTRAVIOLET-INDUCED SKIN TUMORS FROM NORMAL INDIVIDUALS AND XERODERMA PIGMENTOSUM PATIENTS

1992 ◽  
pp. 386-391
Author(s):  
Alain Sarasin ◽  
Caroline Robert-Knebelmann ◽  
Leela Daya-Grosjean ◽  
Alvaro Margulis ◽  
Mohamed Zghal
Keyword(s):  
Xeroderma Pigmentosum ◽  
Skin Tumors ◽  
Normal Individuals ◽  
Oncogene Activation

scholarly journals Neurogenic bladder associated with xeroderma pigmentosum type A: A case report and literature review

2019 ◽  
Vol 27 ◽  
pp. 100996
Author(s):  
Katsuki Tsuchiyama ◽  
Yoshitaka Aoki ◽  
Hideaki Ito ◽  
Makoto Yoneda ◽  
Osamu Yokoyama
Keyword(s):  
Case Report ◽  
Literature Review ◽  
Neurogenic Bladder ◽  
Xeroderma Pigmentosum ◽  
Type A

Oncolytic Vaccinia virus safely and effectively treats skin tumors in mouse models of xeroderma pigmentosum

2012 ◽  
Vol 132 (3) ◽  
pp. 726-731 ◽  
Author(s):  
Jan Brun ◽  
Douglas J. Mahoney ◽  
Fabrice Le Boeuf ◽  
Charles Lefebvre ◽  
Cina A. Sanaei ◽  
...  
Keyword(s):  
Vaccinia Virus ◽  
Mouse Models ◽  
Xeroderma Pigmentosum ◽  
Skin Tumors

scholarly journals Xeroderma Pigmentosum – A Social Stigma Report in Two Siblings and Literature Review

2014 ◽  
Vol 38 (1) ◽  
pp. 40-43
Author(s):  
Tushar Jagzape ◽  
Arunita Bagga ◽  
Amol Gupta ◽  
Damodhar Balpande
Keyword(s):  
Child Health ◽  
Literature Review ◽  
Early Development ◽  
Xeroderma Pigmentosum ◽  
Autosomal Recessive ◽  
Social Stigma ◽  
Exposed Skin ◽  
Senile Changes

Xeroderma pigmentosum is an autosomal recessive, rare pigmentary atrophic disease of childhood that progresses to early development of senile changes in sun-exposed skin. Xeroderma pigmentosum (XP) was first described in 1874 by Hebra and Kaposi. In 1882, Kaposi coined the term xeroderma pigmentosum for the condition, referring to its characteristic dry, pigmented skin. Xeroderma pigmentosum is also known as DeSanctis- Cacchione syndrome. DOI: http://dx.doi.org/10.3329/bjch.v38i1.20026 Bangladesh J Child Health 2014; VOL 38 (1) : 40-43

Sign in / Sign up

Export Citation Format

Share Document